Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $12.23 Analyst target: $35.10 Upside: 187.00%
Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.
See the full interactive analysis & chart →Informational only — not investment advice.